Tokyo, Japan

Yoshiyuki Takasu

This inventor holds 3 USPTO granted patents. Top assignee: Daiichi Pharmaceutical Co., Ltd.. Active years: 1999-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshiyuki Takasu. Retrieved from https://idiyas.com/inventor/yoshiyuki-takasu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1999-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Yoshiyuki Takasu

Introduction

Yoshiyuki Takasu is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of neuropharmacology, particularly in methods aimed at aiding recovery from strokes. With a total of 3 patents, his work focuses on improving the quality of life for post-stroke patients.

Latest Patents

Takasu's latest patents include a method for aiding cerebral recovery following neurodegeneration. This method involves the administration of nefiracetam to improve recovery after a stroke in mammals. Another significant patent is a method for improving disturbances of activities of daily living in post-stroke patients through early administration of nefiracetam. Both methods aim to enhance recovery outcomes for individuals affected by strokes.

Career Highlights

Yoshiyuki Takasu is currently associated with Daiichi Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His research and inventions have the potential to transform treatment protocols for stroke recovery, making a meaningful impact on patient care.

Collaborations

Takasu has collaborated with esteemed colleagues such as Eiichi Otomo and Tadashi Shiotani. Their combined expertise contributes to the advancement of research in neuropharmacology.

Conclusion

Yoshiyuki Takasu's innovative work in stroke recovery methods showcases his dedication to improving patient outcomes. His contributions to the field are invaluable and highlight the importance of continued research in neuropharmacology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…